Hyperbolic Tapering Resources You Can Share With Your Doctor

I know tapering off psychiatric meds can feel overwhelming and scary—it's a big step, and you're not alone in wanting to do it safely.

If you're preparing to talk with your prescriber, here's some Evidence-Based Support on hyperbolic tapering: a patient-centered way to ease down your dose with smaller cuts as your dose drops (like 10% of your current dose). This approach helps your body adjust smoothly and reduces the tough withdrawal or relapse risks.

Understanding Hyperbolic Tapering

These resources draw from a variety of experts, guidelines, and studies to give you a well-rounded view—print them or share digitally to help guide a plan that honors your needs. To view resources for stopping antidepressants, click on the provided link.

Key Resources for Hyperbolic Tapering

• The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (2024) by Mark Horowitz and David Taylor: This comprehensive guide emphasizes hyperbolic tapering for safe deprescribing and stopping antidepressants and other psych meds. It includes practical steps like proportional reductions (e.g., smaller increments at lower doses) over weeks to years, tailored to minimize withdrawal based on receptor occupancy science. Link: The Maudsley Deprescribing Guidelines

  
  

• Hyperbolic Tapering of Antidepressants: Where Are We Now? (2025) by Mark Horowitz et al.: This review highlights the current state of hyperbolic tapering, focusing on its role in achieving linear reductions in brain effects to prevent severe symptoms. It calls for more personalized approaches in clinical practice. Link: Where Are We Now?

  
  

• Outcomes of Hyperbolic Tapering of Antidepressants (Therapeutic Advances in Psychopharmacology, 2023) by Peter C. Groot and Jim van Os: This study analyzes 608 patients using tapering strips for hyperbolic dose reductions (e.g., daily micro-cuts). It shows reduced withdrawal symptoms, especially for venlafaxine and paroxetine, validating this method for patient-centered, gradual tapers. Link: Outcomes of Hyperbolic Tapering

  
  

• A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (Schizophrenia Bulletin, 2021) by Mark Horowitz et al.: This paper proposes hyperbolic tapering for antipsychotics (e.g., 25-50% of current dose every 3-6 months). It explains how this method supports D2 receptor adjustments to lower relapse risks gently. Link: Minimize the Risk of Relapse

  
  

• Alternate-Day Dosing to Taper Antidepressants Risks Severe Withdrawal Effects: An In Silico Analysis (Journal of Affective Disorders, 2025) by James R. O'Neill et al.: This study warns against alternate-day methods and advocates for hyperbolic tapering instead. It shows that steady unblocking of serotonin transporters with smaller cuts prevents symptom spikes. Link: Severe Withdrawal Effects

  
  

• The Relationship Between Dose and Serotonin Transporter Occupancy of Antidepressants—A Systematic Review (Molecular Psychiatry, 2021) by Anders Sørensen et al.: This systematic review uses PET scan analysis of 10 antidepressants to reveal hyperbolic dose-response curves. It supports proportional tapering (e.g., 10% monthly) for gradual, safer reductions without abrupt drops. Link: Dose and Serotonin Transporter

  
  

• How to Stop Antidepressants (Therapeutics Initiative, 2025): This guide recommends very gradual hyperbolic tapering over months or years for high-risk patients. It suggests using liquids or compounding for tiny doses, based on UK NICE and specialty guidelines to markedly reduce symptoms. Link: How to Stop Antidepressants

  
  

• Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study (2021) by Peter C. Groot and Jim van Os: This study validates tapering strips that enable precise hyperbolic cuts. Cohort data shows they effectively lower withdrawal symptom severity for personalized deprescribing. Link: Successful Use of Tapering Strips

  
  

• Withdrawing from Antidepressants (PhD Thesis, 2022) by Anders Sørensen: This thesis explores hyperbolic curves in dose-SERT occupancy. It suggests slower, proportional tapers to ease symptoms and includes a meta-analysis and critiques of standard guidelines. Full PDF available. Link: Withdrawing from Antidepressants

  
  

• Tapering of SSRI Treatment to Mitigate Withdrawal Symptoms (The Lancet Psychiatry, 2019) by Mark Horowitz and David Taylor: This article introduces hyperbolic tapering principles for SSRIs. It provides examples like reducing to sub-milligram doses over extended periods to align with non-linear brain effects. Link: Mitigate Withdrawal Symptoms30032-X/fulltext)

  
  

The Importance of a Personalized Approach

With these diverse insights from guidelines, studies, and experts backing you, take a deep breath—you're taking a courageous step toward what feels right for you. Your well-being is worth advocating for. Remember, it's okay to seek help and gather information. Reach out if you need more support.

HyperbolicTapering PsychMedWithdrawal PatientCenteredCare